ATE551604T1 - Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymer - Google Patents
Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymerInfo
- Publication number
- ATE551604T1 ATE551604T1 AT09742017T AT09742017T ATE551604T1 AT E551604 T1 ATE551604 T1 AT E551604T1 AT 09742017 T AT09742017 T AT 09742017T AT 09742017 T AT09742017 T AT 09742017T AT E551604 T1 ATE551604 T1 AT E551604T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- solubility
- polymer
- crystalline
- solids
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 8
- 229940079593 drug Drugs 0.000 abstract 8
- 239000007787 solid Substances 0.000 abstract 3
- 238000002425 crystallisation Methods 0.000 abstract 2
- 230000008025 crystallization Effects 0.000 abstract 2
- 238000009646 cryomilling Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000000113 differential scanning calorimetry Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920002959 polymer blend Polymers 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analyzing Materials Using Thermal Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5041308P | 2008-05-05 | 2008-05-05 | |
| PCT/EP2009/055233 WO2009135799A2 (en) | 2008-05-05 | 2009-04-29 | Method for evaluating the solubility of a crystalline substance in a polymer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE551604T1 true ATE551604T1 (de) | 2012-04-15 |
Family
ID=41010395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09742017T ATE551604T1 (de) | 2008-05-05 | 2009-04-29 | Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9004752B2 (de) |
| EP (1) | EP2274609B1 (de) |
| AT (1) | ATE551604T1 (de) |
| CA (1) | CA2723398C (de) |
| HR (1) | HRP20120475T1 (de) |
| WO (1) | WO2009135799A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2526413A1 (de) | 2010-01-22 | 2012-11-28 | Abbott GmbH & Co. KG | Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymer |
| WO2013056108A2 (en) * | 2011-10-14 | 2013-04-18 | Array Biopharma Inc. | Solid dispersion |
| CN104483343B (zh) * | 2014-12-29 | 2017-11-14 | 成都光明光电股份有限公司 | 晶化热处理的温度测量方法 |
| EP4220159A1 (de) * | 2022-01-27 | 2023-08-02 | Fundació Institut de Recerca Biomèdica (IRB Barcelona) | Wirkstoffentdeckungstest zum screening von verbindungen |
| CN116813542A (zh) * | 2022-03-21 | 2023-09-29 | 山东新时代药业有限公司 | 米力农的药物多晶体 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE36736E (en) * | 1989-02-06 | 2000-06-13 | Hoffman-La Roche Inc. | Substituted pyrroles |
| US4908801A (en) * | 1989-05-30 | 1990-03-13 | Teledyne Exploration | Real-time simulation of the far-field signature of a seismic sound source array |
| US5468860A (en) * | 1992-11-19 | 1995-11-21 | Merck & Co., Inc. | New finasteride processes |
| TW448160B (en) * | 1993-12-28 | 2001-08-01 | Merck & Co Inc | Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists |
| DE19903333A1 (de) * | 1999-01-28 | 2000-08-10 | Consortium Elektrochem Ind | Herstellung von alpha, beta-ungesättigte Carbonsäurereste enthaltenden Organosiliciumverbindungen |
| US6469179B1 (en) * | 2000-10-03 | 2002-10-22 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| FR2815718B1 (fr) * | 2000-10-20 | 2002-12-06 | Inst Francais Du Petrole | Methode d'evaluation de la temperature de transition vitreuse d'une piece en polymere en cours d'utilisation |
| US20020161168A1 (en) * | 2000-10-27 | 2002-10-31 | Shalaby Shalaby W. | Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
| JP2005532994A (ja) * | 2002-01-24 | 2005-11-04 | ロレアル | 半結晶性重合体およびエステルを含む組成物 |
| JP4520719B2 (ja) * | 2003-10-09 | 2010-08-11 | 東セロ株式会社 | 熱融着性プロピレン系重合体積層フィルム及びその用途 |
| CA2611081C (en) * | 2005-06-03 | 2016-05-31 | Egalet A/S | A drug delivery system for delivering active substances dispersed in a dispersion medium |
| JP2009510213A (ja) * | 2005-09-26 | 2009-03-12 | ディーエスエム アイピー アセッツ ビー.ブイ. | ポリマー粒子の被覆のための方法 |
| US7713595B2 (en) * | 2005-10-18 | 2010-05-11 | Nitto Denko Corporation | Optical compensation films produced by a carrier-web-casting process |
| KR20080086480A (ko) * | 2005-12-02 | 2008-09-25 | 후지필름 가부시키가이샤 | 광학 보상 필름, 편광판 및 액정 디스플레이 장치 |
| GB0612929D0 (en) * | 2006-06-29 | 2006-08-09 | Univ Cambridge Tech | High-performance organic field-effect transistors based on dilute, crystalline-crystalline polymer blends and block copolymers |
| JP2008052041A (ja) * | 2006-08-24 | 2008-03-06 | Fujifilm Corp | 光学フィルム、偏光板、液晶表示装置 |
| FR2930947B1 (fr) * | 2008-05-07 | 2011-03-11 | Arkema France | Composition renfermant un polymere vinylique halogene et un copolymere porteur de groupes associatifs |
| US8158245B2 (en) * | 2009-09-24 | 2012-04-17 | Cytec Technology Corp. | Thermoplastic composites and methods of making and using same |
| US20110256406A1 (en) * | 2011-01-13 | 2011-10-20 | Sabic Innovative Plastics Ip B.V. | Laser Weldable Thermoplastic Polyester Composition |
| US20140012534A1 (en) * | 2012-07-04 | 2014-01-09 | Christopher D. Prest | Non-destructive method to determine crystallinity in amorphous alloy using specific heat capacity |
-
2009
- 2009-04-29 AT AT09742017T patent/ATE551604T1/de active
- 2009-04-29 CA CA2723398A patent/CA2723398C/en active Active
- 2009-04-29 WO PCT/EP2009/055233 patent/WO2009135799A2/en not_active Ceased
- 2009-04-29 EP EP09742017A patent/EP2274609B1/de active Active
- 2009-04-29 US US12/989,396 patent/US9004752B2/en active Active
- 2009-04-29 HR HRP20120475AT patent/HRP20120475T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2723398A1 (en) | 2009-11-12 |
| EP2274609B1 (de) | 2012-03-28 |
| US9004752B2 (en) | 2015-04-14 |
| WO2009135799A2 (en) | 2009-11-12 |
| WO2009135799A3 (en) | 2010-01-28 |
| HRP20120475T1 (hr) | 2012-08-31 |
| US20110261857A1 (en) | 2011-10-27 |
| EP2274609A2 (de) | 2011-01-19 |
| CA2723398C (en) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Enhanced drug loading in the drug-in-adhesive transdermal patch utilizing a drug–ionic liquid strategy: insight into the role of ionic hydrogen bonding | |
| Casian et al. | Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms | |
| Ewing et al. | Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging | |
| Prasad et al. | Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug–polymer–polymer ternary solution | |
| Liu et al. | Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit® E PO solid dispersions | |
| Çelik | Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation | |
| ATE551604T1 (de) | Verfahren zur beurteilung der löslichkeit eines kristallinen stoffes in einem polymer | |
| Takano et al. | Quantitative analysis of the effect of supersaturation on in vivo drug absorption | |
| Pajander et al. | Behaviour of HPMC compacts investigated using UV-imaging | |
| Pawar et al. | Design and evaluation of topical diclofenac sodium gel using hot melt extrusion technology as a continuous manufacturing process with Kolliphor® P407 | |
| Nagy et al. | Use of supercritical CO2‐aided and conventional melt extrusion for enhancing the dissolution rate of an active pharmaceutical ingredient | |
| Ha et al. | Solvent effect and solubility modeling of rebamipide in twelve solvents at different temperatures | |
| Velasco et al. | pH-sensitive polymer hydrogels derived from morpholine to prevent the crystallization of ibuprofen | |
| Gunnam et al. | High-solubility salts of the multiple sclerosis drug teriflunomide | |
| Port et al. | Differential solution behavior of the new API–API co-crystal of tramadol–celecoxib (CTC) versus its constituents and their combination | |
| US20130028955A1 (en) | Sustained release oral matrix and methods of making thereof | |
| Sheikh et al. | Formulation design, characterization and in vitro drug release study of orodispersible film comprising BCS class II drugs. | |
| Khonsari et al. | Formulation and evaluation of in-vitro characterization of gastic-mucoadhesive microparticles/discs containing metformin hydrochloride | |
| Uekusa et al. | Precipitation behavior of pioglitazone on the particle surface of hydrochloride salt in biorelevant media | |
| Bhola et al. | Solubility modeling of a bupivacaine hydrochloride in various solvents over a wide temperature range | |
| McCoy et al. | Packing polymorphism of dapivirine and its impact on the performance of a dapivirine-releasing silicone elastomer vaginal ring | |
| Isaac et al. | Co-milling of telmisartan with poly (vinyl alcohol)–an alkalinizer free green approach to ensure its bioavailability | |
| Raza et al. | Self-assembled zein organogels as in situ forming implant drug delivery system and 3D printing ink | |
| Drašković et al. | Comprehensive evaluation of formulation factors affecting critical quality attributes of casted orally disintegrating films | |
| He | Integration of physical, chemical, mechanical, and biopharmaceutical properties in solid oral dosage form development |